An official website of the United States government
RFA-CA-23-002 - Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
On This Page: 4
Active NOSIs
| Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
|---|---|---|---|---|---|
| Notice of Special Interest (NOSI): RNA Modifications in Cancer Biology | NOT-CA-23-060 | NCI | Apr 17, 2023 | Jan 8, 2026 | R33, R21, U01, R61, R03 |
Expired NOSIs
| Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
|---|---|---|---|---|---|
| Notice of Special Interest (NOSI): Technology Development for Cancer Control and Population Science Research | NOT-CA-23-037 | NCI | Jan 18, 2023 | Dec 31, 2024 | U01, R21, R61, R33, U24 |
| Notice of Special Interest (NOSI): Technologies and Informatics Tools for Cancer Metabolomics | NOT-CA-22-083 | NCI | Apr 26, 2022 | Dec 31, 2024 | R33, R61, R21, U24, U01 |
| Notice of Special Interest (NOSI): RNA Modifications in Cancer Biology | NOT-CA-22-003 | NCI | Nov 30, 2021 | May 8, 2023 | R03, R61, R33, R21 |
